CA2718382A1

CA2718382A1 - C2orf18 as target gene for cancer therapy and diagnosis

C2orf18 as target gene for cancer therapy and diagnosis Download PDF

Info

Publication number: CA2718382A1
Authority: CA; Canada
Prior art keywords: c2orf; polypeptide; gene; c2orf18; cancer
Prior art date: 2008-03-12
Legal status : Abandoned

Application number

CA2718382A

Other languages

English (en)

French (fr)

Inventor

Yusuke Nakamura

Hidewaki Nakagawa

Shuichi Nakatsuru

Current Assignee

Oncotherapy Science Inc

Original Assignee

Oncotherapy Science Inc

Priority date

2008-03-12

Filing date

2009-03-10

Publication date

2009-09-17

2009-03-10 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2009-09-17 Publication of CA2718382A1 publication Critical patent/CA2718382A1/en

Status Abandoned legal-status Critical Current

Links

102100032109 Solute carrier family 35 member F6 Human genes 0.000 title claims abstract description 63
101000637757 Homo sapiens Solute carrier family 35 member F6 Proteins 0.000 title claims abstract description 44
108090000623 proteins and genes Proteins 0.000 title claims description 297
238000003745 diagnosis Methods 0.000 title description 9
238000011275 oncology therapy Methods 0.000 title description 2
238000000034 method Methods 0.000 claims abstract description 237
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 229
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 203
229920001184 polypeptide Polymers 0.000 claims abstract description 189
206010028980 Neoplasm Diseases 0.000 claims abstract description 177
201000011510 cancer Diseases 0.000 claims abstract description 165
230000014509 gene expression Effects 0.000 claims abstract description 147
206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 105
208000015486 malignant pancreatic neoplasm Diseases 0.000 claims abstract description 103
208000008443 pancreatic carcinoma Diseases 0.000 claims abstract description 103
201000002528 pancreatic cancer Diseases 0.000 claims abstract description 98
238000012216 screening Methods 0.000 claims abstract description 73
230000002401 inhibitory effect Effects 0.000 claims abstract description 61
239000013598 vector Substances 0.000 claims abstract description 54
239000000203 mixture Substances 0.000 claims abstract description 49
102000040430 polynucleotide Human genes 0.000 claims abstract description 38
108091033319 polynucleotide Proteins 0.000 claims abstract description 38
239000002157 polynucleotide Substances 0.000 claims abstract description 38
230000010261 cell growth Effects 0.000 claims abstract description 34
239000003795 chemical substances by application Substances 0.000 claims description 254
150000001875 compounds Chemical class 0.000 claims description 233
102000004169 proteins and genes Human genes 0.000 claims description 205
238000012360 testing method Methods 0.000 claims description 179
230000027455 binding Effects 0.000 claims description 109
150000007523 nucleic acids Chemical class 0.000 claims description 105
102000039446 nucleic acids Human genes 0.000 claims description 98
108020004707 nucleic acids Proteins 0.000 claims description 98
102100026396 ADP/ATP translocase 2 Human genes 0.000 claims description 90
230000000692 anti-sense effect Effects 0.000 claims description 90
101000718417 Homo sapiens ADP/ATP translocase 2 Proteins 0.000 claims description 89
125000003729 nucleotide group Chemical group 0.000 claims description 89
239000002773 nucleotide Substances 0.000 claims description 86
230000000694 effects Effects 0.000 claims description 57
108091081021 Sense strand Proteins 0.000 claims description 47
150000001413 amino acids Chemical class 0.000 claims description 41
230000000295 complement effect Effects 0.000 claims description 38
230000004071 biological effect Effects 0.000 claims description 36
125000003275 alpha amino acid group Chemical group 0.000 claims description 35
108020004999 messenger RNA Proteins 0.000 claims description 35
239000000523 sample Substances 0.000 claims description 31
230000000875 corresponding effect Effects 0.000 claims description 25
230000001105 regulatory effect Effects 0.000 claims description 25
108700008625 Reporter Genes Proteins 0.000 claims description 22
239000004480 active ingredient Substances 0.000 claims description 22
230000002103 transcriptional effect Effects 0.000 claims description 16
239000012472 biological sample Substances 0.000 claims description 15
238000009396 hybridization Methods 0.000 claims description 14
230000004663 cell proliferation Effects 0.000 claims description 9
230000002062 proliferating effect Effects 0.000 claims description 8
239000005557 antagonist Substances 0.000 claims description 7
238000001574 biopsy Methods 0.000 claims description 5
108091027568 Single-stranded nucleotide Proteins 0.000 claims description 4
239000000556 agonist Substances 0.000 claims description 4
239000003937 drug carrier Substances 0.000 claims description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 57
201000010099 disease Diseases 0.000 abstract description 54
238000011282 treatment Methods 0.000 abstract description 37
239000003814 drug Substances 0.000 abstract description 27
208000024891 symptom Diseases 0.000 abstract description 10
229940124597 therapeutic agent Drugs 0.000 abstract description 9
238000002405 diagnostic procedure Methods 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 364
235000018102 proteins Nutrition 0.000 description 197
101150078635 18 gene Proteins 0.000 description 117
201000008129 pancreatic ductal adenocarcinoma Diseases 0.000 description 89
239000012634 fragment Substances 0.000 description 53
239000004055 small Interfering RNA Substances 0.000 description 42
235000001014 amino acid Nutrition 0.000 description 39
229940024606 amino acid Drugs 0.000 description 38
108020004459 Small interfering RNA Proteins 0.000 description 37
239000000126 substance Substances 0.000 description 36
210000001519 tissue Anatomy 0.000 description 36
230000001225 therapeutic effect Effects 0.000 description 34
239000002502 liposome Substances 0.000 description 32
239000003153 chemical reaction reagent Substances 0.000 description 30
101710088609 Solute carrier family 35 member F6 Proteins 0.000 description 26
230000006870 function Effects 0.000 description 26
238000001514 detection method Methods 0.000 description 24
238000002347 injection Methods 0.000 description 23
239000007924 injection Substances 0.000 description 23
239000002299 complementary DNA Substances 0.000 description 22
230000006907 apoptotic process Effects 0.000 description 21
230000004048 modification Effects 0.000 description 20
238000012986 modification Methods 0.000 description 20
239000000047 product Substances 0.000 description 20
230000003993 interaction Effects 0.000 description 19
238000001262 western blot Methods 0.000 description 19
238000004458 analytical method Methods 0.000 description 18
108091034117 Oligonucleotide Proteins 0.000 description 17
239000008194 pharmaceutical composition Substances 0.000 description 17
239000000463 material Substances 0.000 description 16
210000003470 mitochondria Anatomy 0.000 description 16
238000009472 formulation Methods 0.000 description 15
230000001965 increasing effect Effects 0.000 description 15
238000002372 labelling Methods 0.000 description 15
238000004519 manufacturing process Methods 0.000 description 15
238000010647 peptide synthesis reaction Methods 0.000 description 15
230000008569 process Effects 0.000 description 15
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 14
108060003951 Immunoglobulin Proteins 0.000 description 13
102000018358 immunoglobulin Human genes 0.000 description 13
239000003112 inhibitor Substances 0.000 description 13
210000001700 mitochondrial membrane Anatomy 0.000 description 13
230000002018 overexpression Effects 0.000 description 13
238000002360 preparation method Methods 0.000 description 13
238000013519 translation Methods 0.000 description 13
238000005406 washing Methods 0.000 description 13
108010047041 Complementarity Determining Regions Proteins 0.000 description 12
239000002202 Polyethylene glycol Substances 0.000 description 12
239000011324 bead Substances 0.000 description 12
239000000872 buffer Substances 0.000 description 12
239000013604 expression vector Substances 0.000 description 12
238000000338 in vitro Methods 0.000 description 12
229920001223 polyethylene glycol Polymers 0.000 description 12
238000003556 assay Methods 0.000 description 11
108020001507 fusion proteins Proteins 0.000 description 11
102000037865 fusion proteins Human genes 0.000 description 11
230000012010 growth Effects 0.000 description 11
230000035755 proliferation Effects 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
108091027967 Small hairpin RNA Proteins 0.000 description 10
239000000427 antigen Substances 0.000 description 10
108091007433 antigens Proteins 0.000 description 10
102000036639 antigens Human genes 0.000 description 10
230000008901 benefit Effects 0.000 description 10
238000012875 competitive assay Methods 0.000 description 10
230000003247 decreasing effect Effects 0.000 description 10
210000002919 epithelial cell Anatomy 0.000 description 10
BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 10
238000001114 immunoprecipitation Methods 0.000 description 10
239000007788 liquid Substances 0.000 description 10
239000012528 membrane Substances 0.000 description 10
230000003278 mimic effect Effects 0.000 description 10
239000000843 powder Substances 0.000 description 10
238000003757 reverse transcription PCR Methods 0.000 description 10
238000010186 staining Methods 0.000 description 10
238000003786 synthesis reaction Methods 0.000 description 10
239000003826 tablet Substances 0.000 description 10
238000013459 approach Methods 0.000 description 9
230000001413 cellular effect Effects 0.000 description 9
230000007423 decrease Effects 0.000 description 9
230000002438 mitochondrial effect Effects 0.000 description 9
239000013642 negative control Substances 0.000 description 9
239000000243 solution Substances 0.000 description 9
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
102000005720 Glutathione transferase Human genes 0.000 description 8
108010070675 Glutathione transferase Proteins 0.000 description 8
241000283973 Oryctolagus cuniculus Species 0.000 description 8
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
-1 antibody Proteins 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
239000000284 extract Substances 0.000 description 8
238000001802 infusion Methods 0.000 description 8
239000003446 ligand Substances 0.000 description 8
238000012544 monitoring process Methods 0.000 description 8
210000000056 organ Anatomy 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
230000002265 prevention Effects 0.000 description 8
MYFATKRONKHHQL-UHFFFAOYSA-N rhodamine 123 Chemical compound [Cl-].COC(=O)C1=CC=CC=C1C1=C2C=CC(=[NH2+])C=C2OC2=CC(N)=CC=C21 MYFATKRONKHHQL-UHFFFAOYSA-N 0.000 description 8
238000010396 two-hybrid screening Methods 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
102000004190 Enzymes Human genes 0.000 description 7
108090000790 Enzymes Proteins 0.000 description 7
238000000636 Northern blotting Methods 0.000 description 7
108091028043 Nucleic acid sequence Proteins 0.000 description 7
108700020796 Oncogene Proteins 0.000 description 7
238000011161 development Methods 0.000 description 7
229940079593 drug Drugs 0.000 description 7
229940088598 enzyme Drugs 0.000 description 7
238000002991 immunohistochemical analysis Methods 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
150000002632 lipids Chemical class 0.000 description 7
230000000717 retained effect Effects 0.000 description 7
230000001629 suppression Effects 0.000 description 7
238000001890 transfection Methods 0.000 description 7
238000011144 upstream manufacturing Methods 0.000 description 7
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
108020004414 DNA Proteins 0.000 description 6
102100039556 Galectin-4 Human genes 0.000 description 6
101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 6
238000012288 TUNEL assay Methods 0.000 description 6
238000007792 addition Methods 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
239000002775 capsule Substances 0.000 description 6
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
229960002143 fluorescein Drugs 0.000 description 6
230000001976 improved effect Effects 0.000 description 6
230000036963 noncompetitive effect Effects 0.000 description 6
230000036961 partial effect Effects 0.000 description 6
238000003752 polymerase chain reaction Methods 0.000 description 6
229920001451 polypropylene glycol Polymers 0.000 description 6
229920001282 polysaccharide Polymers 0.000 description 6
239000005017 polysaccharide Substances 0.000 description 6
150000004804 polysaccharides Chemical class 0.000 description 6
238000004393 prognosis Methods 0.000 description 6
238000000746 purification Methods 0.000 description 6
230000009467 reduction Effects 0.000 description 6
238000006722 reduction reaction Methods 0.000 description 6
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
239000002904 solvent Substances 0.000 description 6
239000000758 substrate Substances 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
238000002560 therapeutic procedure Methods 0.000 description 6
238000013518 transcription Methods 0.000 description 6
230000035897 transcription Effects 0.000 description 6
230000035899 viability Effects 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
102000014914 Carrier Proteins Human genes 0.000 description 5
102000016359 Fibronectins Human genes 0.000 description 5
108010067306 Fibronectins Proteins 0.000 description 5
241000700159 Rattus Species 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
101710120037 Toxin CcdB Proteins 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
125000000539 amino acid group Chemical group 0.000 description 5
108091008324 binding proteins Proteins 0.000 description 5
230000008859 change Effects 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
230000002596 correlated effect Effects 0.000 description 5
210000000805 cytoplasm Anatomy 0.000 description 5
230000001086 cytosolic effect Effects 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
239000000499 gel Substances 0.000 description 5
230000005764 inhibitory process Effects 0.000 description 5
230000002452 interceptive effect Effects 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
239000013641 positive control Substances 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
239000000725 suspension Substances 0.000 description 5
239000003981 vehicle Substances 0.000 description 5
210000005253 yeast cell Anatomy 0.000 description 5
108090001008 Avidin Proteins 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 4
102000053602 DNA Human genes 0.000 description 4
102000007260 Deoxyribonuclease I Human genes 0.000 description 4
108010008532 Deoxyribonuclease I Proteins 0.000 description 4
229920002307 Dextran Polymers 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
241000124008 Mammalia Species 0.000 description 4
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
108091028664 Ribonucleotide Proteins 0.000 description 4
229920002684 Sepharose Polymers 0.000 description 4
229930006000 Sucrose Natural products 0.000 description 4
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 4
230000001594 aberrant effect Effects 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
239000002246 antineoplastic agent Substances 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
235000020958 biotin Nutrition 0.000 description 4
239000011616 biotin Substances 0.000 description 4
VTJUKNSKBAOEHE-UHFFFAOYSA-N calixarene Chemical compound COC(=O)COC1=C(CC=2C(=C(CC=3C(=C(C4)C=C(C=3)C(C)(C)C)OCC(=O)OC)C=C(C=2)C(C)(C)C)OCC(=O)OC)C=C(C(C)(C)C)C=C1CC1=C(OCC(=O)OC)C4=CC(C(C)(C)C)=C1 VTJUKNSKBAOEHE-UHFFFAOYSA-N 0.000 description 4
239000000969 carrier Substances 0.000 description 4
230000015556 catabolic process Effects 0.000 description 4
238000007385 chemical modification Methods 0.000 description 4
239000012707 chemical precursor Substances 0.000 description 4
238000010276 construction Methods 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
238000010353 genetic engineering Methods 0.000 description 4
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
239000008187 granular material Substances 0.000 description 4
239000001963 growth medium Substances 0.000 description 4
210000002216 heart Anatomy 0.000 description 4
229910052739 hydrogen Inorganic materials 0.000 description 4
238000003018 immunoassay Methods 0.000 description 4
238000001361 intraarterial administration Methods 0.000 description 4
238000001990 intravenous administration Methods 0.000 description 4
210000003734 kidney Anatomy 0.000 description 4
210000004072 lung Anatomy 0.000 description 4
238000004949 mass spectrometry Methods 0.000 description 4
238000005259 measurement Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
229930182817 methionine Natural products 0.000 description 4
210000004923 pancreatic tissue Anatomy 0.000 description 4
239000003755 preservative agent Substances 0.000 description 4
230000001737 promoting effect Effects 0.000 description 4
239000002336 ribonucleotide Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
239000000375 suspending agent Substances 0.000 description 4
230000002407 ATP formation Effects 0.000 description 3
229920000936 Agarose Polymers 0.000 description 3
102100026189 Beta-galactosidase Human genes 0.000 description 3
208000024172 Cardiovascular disease Diseases 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 3
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
101150009006 HIS3 gene Proteins 0.000 description 3
108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 3
239000012097 Lipofectamine 2000 Substances 0.000 description 3
108060001084 Luciferase Proteins 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108010058682 Mitochondrial Proteins Proteins 0.000 description 3
102000006404 Mitochondrial Proteins Human genes 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
239000004793 Polystyrene Substances 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
102100022056 Serum response factor Human genes 0.000 description 3
108091081024 Start codon Proteins 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
230000003321 amplification Effects 0.000 description 3
229940041181 antineoplastic drug Drugs 0.000 description 3
108010005774 beta-Galactosidase Proteins 0.000 description 3
239000011230 binding agent Substances 0.000 description 3
230000037396 body weight Effects 0.000 description 3
231100000504 carcinogenesis Toxicity 0.000 description 3
101150055766 cat gene Proteins 0.000 description 3
230000022131 cell cycle Effects 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
238000002512 chemotherapy Methods 0.000 description 3
235000012000 cholesterol Nutrition 0.000 description 3
238000010293 colony formation assay Methods 0.000 description 3
230000001332 colony forming effect Effects 0.000 description 3
238000004590 computer program Methods 0.000 description 3
238000005094 computer simulation Methods 0.000 description 3
239000013068 control sample Substances 0.000 description 3
238000012258 culturing Methods 0.000 description 3
230000007547 defect Effects 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
239000005547 deoxyribonucleotide Substances 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
208000035475 disorder Diseases 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
230000002349 favourable effect Effects 0.000 description 3
239000012091 fetal bovine serum Substances 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
239000012530 fluid Substances 0.000 description 3
235000013355 food flavoring agent Nutrition 0.000 description 3
238000005194 fractionation Methods 0.000 description 3
238000010230 functional analysis Methods 0.000 description 3
230000034659 glycolysis Effects 0.000 description 3
238000012405 in silico analysis Methods 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000007918 intramuscular administration Methods 0.000 description 3
101150066555 lacZ gene Proteins 0.000 description 3
230000004807 localization Effects 0.000 description 3
239000006166 lysate Substances 0.000 description 3
230000036210 malignancy Effects 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
102000013415 peroxidase activity proteins Human genes 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
239000008363 phosphate buffer Substances 0.000 description 3
229920002223 polystyrene Polymers 0.000 description 3
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 3
238000003825 pressing Methods 0.000 description 3
238000002203 pretreatment Methods 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
230000004960 subcellular localization Effects 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
229920001059 synthetic polymer Polymers 0.000 description 3
230000008685 targeting Effects 0.000 description 3
AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 2
102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
208000005623 Carcinogenesis Diseases 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
101710205889 Cytochrome b562 Proteins 0.000 description 2
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
102100031780 Endonuclease Human genes 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
108010024636 Glutathione Proteins 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
241000282412 Homo Species 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
206010021143 Hypoxia Diseases 0.000 description 2
108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
235000010643 Leucaena leucocephala Nutrition 0.000 description 2
240000007472 Leucaena leucocephala Species 0.000 description 2
102000019298 Lipocalin Human genes 0.000 description 2
108050006654 Lipocalin Proteins 0.000 description 2
238000000134 MTT assay Methods 0.000 description 2
231100000002 MTT assay Toxicity 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
108091092724 Noncoding DNA Proteins 0.000 description 2
102000005823 Nucleotide-sugar transporter Human genes 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
229920002873 Polyethylenimine Polymers 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 2
108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 2
238000010240 RT-PCR analysis Methods 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
102000039471 Small Nuclear RNA Human genes 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
229920001615 Tragacanth Polymers 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
230000006682 Warburg effect Effects 0.000 description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
235000010443 alginic acid Nutrition 0.000 description 2
239000000783 alginic acid Substances 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
229960001126 alginic acid Drugs 0.000 description 2
150000004781 alginic acids Chemical class 0.000 description 2
230000004075 alteration Effects 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
230000000890 antigenic effect Effects 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
230000001640 apoptogenic effect Effects 0.000 description 2
235000019445 benzyl alcohol Nutrition 0.000 description 2
SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
230000008827 biological function Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
230000036952 cancer formation Effects 0.000 description 2
229910052799 carbon Inorganic materials 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000003833 cell viability Effects 0.000 description 2
238000001311 chemical methods and process Methods 0.000 description 2
238000010367 cloning Methods 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
230000008021 deposition Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
239000002270 dispersing agent Substances 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
239000003995 emulsifying agent Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
210000002472 endoplasmic reticulum Anatomy 0.000 description 2
230000019439 energy homeostasis Effects 0.000 description 2
230000037149 energy metabolism Effects 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
238000013467 fragmentation Methods 0.000 description 2
238000006062 fragmentation reaction Methods 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
238000007429 general method Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
239000011521 glass Substances 0.000 description 2
229960003180 glutathione Drugs 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
229920001477 hydrophilic polymer Polymers 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000007954 hypoxia Effects 0.000 description 2
238000003365 immunocytochemistry Methods 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
238000004255 ion exchange chromatography Methods 0.000 description 2
239000008101 lactose Substances 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
238000011068 loading method Methods 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
229920001427 mPEG Polymers 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000005389 magnetism Effects 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000002493 microarray Methods 0.000 description 2
238000010208 microarray analysis Methods 0.000 description 2
102000035118 modified proteins Human genes 0.000 description 2
108091005573 modified proteins Proteins 0.000 description 2
238000000329 molecular dynamics simulation Methods 0.000 description 2
210000000865 mononuclear phagocyte system Anatomy 0.000 description 2
238000000465 moulding Methods 0.000 description 2
229920005615 natural polymer Polymers 0.000 description 2
230000017095 negative regulation of cell growth Effects 0.000 description 2
108020003699 nucleotide-sugar transporter Proteins 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
150000002482 oligosaccharides Chemical class 0.000 description 2
238000010397 one-hybrid screening Methods 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
239000008188 pellet Substances 0.000 description 2
239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
239000000816 peptidomimetic Substances 0.000 description 2
230000035699 permeability Effects 0.000 description 2
230000008823 permeabilization Effects 0.000 description 2
238000002823 phage display Methods 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000012071 phase Substances 0.000 description 2
229910052698 phosphorus Inorganic materials 0.000 description 2
239000002504 physiological saline solution Substances 0.000 description 2
239000013612 plasmid Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 2
229920002401 polyacrylamide Polymers 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
238000010837 poor prognosis Methods 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
238000002271 resection Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
230000002207 retinal effect Effects 0.000 description 2
238000004366 reverse phase liquid chromatography Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000010703 silicon Substances 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
150000003384 small molecules Chemical class 0.000 description 2
108091029842 small nuclear ribonucleic acid Proteins 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
230000003595 spectral effect Effects 0.000 description 2
239000007921 spray Substances 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
150000005846 sugar alcohols Polymers 0.000 description 2
229910052717 sulfur Inorganic materials 0.000 description 2
239000000829 suppository Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
229920003002 synthetic resin Polymers 0.000 description 2
239000000057 synthetic resin Substances 0.000 description 2
210000001685 thyroid gland Anatomy 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
238000003160 two-hybrid assay Methods 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
238000012800 visualization Methods 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 description 1
MXXGKASZZLDWPV-UHFFFAOYSA-N 5-methylpyrimidine Chemical group CC1=CN=C=N[CH]1 MXXGKASZZLDWPV-UHFFFAOYSA-N 0.000 description 1
LMEHJKJEPRYEEB-UHFFFAOYSA-N 5-prop-1-ynylpyrimidine Chemical compound CC#CC1=CN=CN=C1 LMEHJKJEPRYEEB-UHFFFAOYSA-N 0.000 description 1
208000004998 Abdominal Pain Diseases 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
108700028369 Alleles Proteins 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
208000002109 Argyria Diseases 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
208000008035 Back Pain Diseases 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
238000009010 Bradford assay Methods 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
108091006146 Channels Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
235000019750 Crude protein Nutrition 0.000 description 1
241001559589 Cullen Species 0.000 description 1
229920000858 Cyclodextrin Polymers 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
239000012623 DNA damaging agent Substances 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
239000004338 Dichlorodifluoromethane Substances 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101710202200 Endolysin A Proteins 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
244000059224 Gaultheria adenothrix Species 0.000 description 1
235000001721 Gaultheria adenothrix Nutrition 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 description 1
101100108264 Homo sapiens SLC25A5 gene Proteins 0.000 description 1
101000629635 Homo sapiens Signal recognition particle receptor subunit alpha Proteins 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
238000003231 Lowry assay Methods 0.000 description 1
238000009013 Lowry's assay Methods 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
102100026639 MICOS complex subunit MIC60 Human genes 0.000 description 1
101710128942 MICOS complex subunit MIC60 Proteins 0.000 description 1
102100024295 Maltase-glucoamylase Human genes 0.000 description 1
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
238000007807 Matrigel invasion assay Methods 0.000 description 1
108090000301 Membrane transport proteins Proteins 0.000 description 1
102000003939 Membrane transport proteins Human genes 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
108010067028 Mitochondrial Permeability Transition Pore Proteins 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101001059625 Mytilus californianus Fibronectin type III domain-containing protein Proteins 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
241000283283 Orcinus orca Species 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
241000282579 Pan Species 0.000 description 1
TYMABNNERDVXID-DLYFRVTGSA-N Panipenem Chemical compound C([C@@H]1[C@H](C(N1C=1C(O)=O)=O)[C@H](O)C)C=1S[C@H]1CCN(C(C)=N)C1 TYMABNNERDVXID-DLYFRVTGSA-N 0.000 description 1
241000282520 Papio Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
229920002230 Pectic acid Polymers 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
201000007902 Primary cutaneous amyloidosis Diseases 0.000 description 1
HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
206010036790 Productive cough Diseases 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
108091006715 SLC25A5 Proteins 0.000 description 1
101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102100026900 Signal recognition particle receptor subunit alpha Human genes 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229930182558 Sterol Natural products 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
241000282887 Suidae Species 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102100031274 Translocator protein Human genes 0.000 description 1
101710166801 Translocator protein Proteins 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102000004243 Tubulin Human genes 0.000 description 1
108090000704 Tubulin Proteins 0.000 description 1
101710159648 Uncharacterized protein Proteins 0.000 description 1
108091023045 Untranslated Region Proteins 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
241000711975 Vesicular stomatitis virus Species 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
235000010489 acacia gum Nutrition 0.000 description 1
239000001785 acacia senegal l. willd gum Substances 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
238000005377 adsorption chromatography Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000009824 affinity maturation Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
108010028144 alpha-Glucosidases Proteins 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
230000006229 amino acid addition Effects 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
239000003708 ampul Substances 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000001857 anti-mycotic effect Effects 0.000 description 1
102000025171 antigen binding proteins Human genes 0.000 description 1
108091000831 antigen binding proteins Proteins 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000002543 antimycotic Substances 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
230000004900 autophagic degradation Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
229960002903 benzyl benzoate Drugs 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
102000006995 beta-Glucosidase Human genes 0.000 description 1
108010047754 beta-Glucosidase Proteins 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000000227 bioadhesive Substances 0.000 description 1
229920002988 biodegradable polymer Polymers 0.000 description 1
239000004621 biodegradable polymer Substances 0.000 description 1
230000002715 bioenergetic effect Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
150000004653 carbonic acids Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
UHBYWPGGCSDKFX-UHFFFAOYSA-N carboxyglutamic acid Chemical compound OC(=O)C(N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-UHFFFAOYSA-N 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
235000010418 carrageenan Nutrition 0.000 description 1
239000000679 carrageenan Substances 0.000 description 1
229920001525 carrageenan Polymers 0.000 description 1
229940113118 carrageenan Drugs 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000010609 cell counting kit-8 assay Methods 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
230000019522 cellular metabolic process Effects 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
238000010382 chemical cross-linking Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
229940000425 combination drug Drugs 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000006957 competitive inhibition Effects 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000003271 compound fluorescence assay Methods 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
239000013078 crystal Substances 0.000 description 1
238000003235 crystal violet staining Methods 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000011498 curative surgery Methods 0.000 description 1
238000009109 curative therapy Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
229940097362 cyclodextrins Drugs 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
239000002274 desiccant Substances 0.000 description 1
238000013461 design Methods 0.000 description 1
230000000368 destabilizing effect Effects 0.000 description 1
229950006137 dexfosfoserine Drugs 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
229940042935 dichlorodifluoromethane Drugs 0.000 description 1
235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
230000009274 differential gene expression Effects 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
238000002224 dissection Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
239000008157 edible vegetable oil Substances 0.000 description 1
239000012636 effector Substances 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000000572 ellipsometry Methods 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
210000004700 fetal blood Anatomy 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
QPJBWNIQKHGLAU-IQZHVAEDSA-N ganglioside GM1 Chemical compound O[C@@H]1[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 QPJBWNIQKHGLAU-IQZHVAEDSA-N 0.000 description 1
150000002270 gangliosides Chemical class 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
229960005277 gemcitabine Drugs 0.000 description 1
SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
239000008103 glucose Substances 0.000 description 1
229940097043 glucuronic acid Drugs 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000003966 growth inhibitor Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000013537 high throughput screening Methods 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
150000002411 histidines Chemical class 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
102000053563 human MYC Human genes 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
239000000017 hydrogel Substances 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
150000002431 hydrogen Chemical group 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
210000004201 immune sera Anatomy 0.000 description 1
229940042743 immune sera Drugs 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
239000007943 implant Substances 0.000 description 1
238000000126 in silico method Methods 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000003701 inert diluent Substances 0.000 description 1
206010022000 influenza Diseases 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
230000002687 intercalation Effects 0.000 description 1
230000002601 intratumoral effect Effects 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
239000007951 isotonicity adjuster Substances 0.000 description 1
238000001001 laser micro-dissection Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
229940040145 liniment Drugs 0.000 description 1
239000000865 liniment Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000001394 metastastic effect Effects 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
LSDPWZHWYPCBBB-UHFFFAOYSA-O methylsulfide anion Chemical compound [SH2+]C LSDPWZHWYPCBBB-UHFFFAOYSA-O 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
210000001589 microsome Anatomy 0.000 description 1
239000004005 microsphere Substances 0.000 description 1
IKEOZQLIVHGQLJ-UHFFFAOYSA-M mitoTracker Red Chemical compound [Cl-].C1=CC(CCl)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 IKEOZQLIVHGQLJ-UHFFFAOYSA-M 0.000 description 1
230000005776 mitochondrial apoptotic pathway Effects 0.000 description 1
230000004898 mitochondrial function Effects 0.000 description 1
230000006677 mitochondrial metabolism Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000002715 modification method Methods 0.000 description 1
239000007932 molded tablet Substances 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000000302 molecular modelling Methods 0.000 description 1
238000009126 molecular therapy Methods 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000003097 mucus Anatomy 0.000 description 1
108091005763 multidomain proteins Proteins 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000002088 nanocapsule Substances 0.000 description 1
229940100662 nasal drops Drugs 0.000 description 1
239000005445 natural material Substances 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
230000008693 nausea Effects 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
230000017074 necrotic cell death Effects 0.000 description 1
230000010807 negative regulation of binding Effects 0.000 description 1
CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000006959 non-competitive inhibition Effects 0.000 description 1
239000002687 nonaqueous vehicle Substances 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000007826 nucleic acid assay Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
238000005457 optimization Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
125000000885 organic scaffold group Chemical group 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
235000010603 pastilles Nutrition 0.000 description 1
LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
229940083251 peripheral vasodilators purine derivative Drugs 0.000 description 1
230000037050 permeability transition Effects 0.000 description 1
235000020030 perry Nutrition 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
150000008104 phosphatidylethanolamines Chemical group 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
239000000419 plant extract Substances 0.000 description 1
239000010773 plant oil Substances 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920000729 poly(L-lysine) polymer Polymers 0.000 description 1
229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
229920000962 poly(amidoamine) Polymers 0.000 description 1
238000007694 polyacrylamide gel isoelectric focusing Methods 0.000 description 1
239000010318 polygalacturonic acid Substances 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229940068968 polysorbate 80 Drugs 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
235000019422 polyvinyl alcohol Nutrition 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000035409 positive regulation of cell proliferation Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000009117 preventive therapy Methods 0.000 description 1
230000009862 primary prevention Effects 0.000 description 1
229960001309 procaine hydrochloride Drugs 0.000 description 1
239000003380 propellant Substances 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
238000012514 protein characterization Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000006268 reductive amination reaction Methods 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
238000011160 research Methods 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
108010008790 ribosomal phosphoprotein P1 Proteins 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
238000005185 salting out Methods 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000007974 sodium acetate buffer Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
239000006104 solid solution Substances 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
229960002920 sorbitol Drugs 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
125000006850 spacer group Chemical group 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
210000003802 sputum Anatomy 0.000 description 1
208000024794 sputum Diseases 0.000 description 1
238000012289 standard assay Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
235000003702 sterols Nutrition 0.000 description 1
150000003432 sterols Chemical class 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000010254 subcutaneous injection Methods 0.000 description 1
239000007929 subcutaneous injection Substances 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
125000004434 sulfur atom Chemical group 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
238000012353 t test Methods 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
239000002562 thickening agent Substances 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
235000010487 tragacanth Nutrition 0.000 description 1
239000000196 tragacanth Substances 0.000 description 1
229940116362 tragacanth Drugs 0.000 description 1
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000014616 translation Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
238000002834 transmittance Methods 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
229940029284 trichlorofluoromethane Drugs 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
238000013042 tunel staining Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
WQAJKOXBERTWBK-UHFFFAOYSA-N verdine Natural products CC1CNC2C(C1)OC3(CCC4C5CCC6(O)CC(O)CC(O)C6(C)C5C(=O)C4=C3C)C2C WQAJKOXBERTWBK-UHFFFAOYSA-N 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
238000010792 warming Methods 0.000 description 1
239000008215 water for injection Substances 0.000 description 1
229920003169 water-soluble polymer Polymers 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
208000016261 weight loss Diseases 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
238000002424 x-ray crystallography Methods 0.000 description 1
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1